Effects of the oral environment on kshv shedding in ugandan adults living with HIV
Active Project Grant Awarded Last action
- Award ID
- DP1CA291173
- Recipient
-
Cincinnati Univ Of UEI DZ4YCZ3QSPR5 Part of The Regents Of The University Of Colorado
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,205,000
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date 42% complete
- Originally
- Place of performance
- Cincinnati, OH 45219, USA
Award details come from USAspending.gov.
Description
- Abstract
- In sub-saharan africa (SSA), kaposi's sarcoma-associated herpesvirus (kshv), the etiological agent of kaposi's sarcoma (KS), is endemic and HIV incidence is high making KS one of the most common cancers in adults associated with high mortality, even in the antiretroviral therapy (art) ERA. Although oral lesions are common among aids-KS patients, the effects of HIV infection on the oral environment and kshv reactivation in the oral cavity before KS development are completely unknown. Using innovative and validated techniques this study will be the first to test the hypothesis that alterations in the oral environment during HIV infection are a critical determinant of kshv reactivation and increased kshv shedding in the oral cavity. I propose a large adequately powered longitudinal study of 600 ugandan adult males and females followed over two years from three groups: people living with HIV (plwh) on long term art, newly diagnosed art-naïve plwh, and HIV uninfected. Participants will be enrolled at the general population cohort (GPC) in rural uganda where kshv seroprevalence is among the highest in the world and at the aids support organization (taso) and aids healthcare foundation (AHF) uganda cares, both longstanding HIV care clinics which serve the GPC area. Oral health examinations will be completed to identify whether plwh exhibit markers of oral disease including gingivitis and periodontitis, resulting in increased kshv reactivation and higher kshv viral loads in saliva (shedders). Oral fluids will be collected to identify whether higher oral inflammatory markers, and lower kshv- specific IGA are associated with oral kshv shedding. To capture the role of HIV on changes causing oral microbiome dysbiosis in the oral cavity and continued effects on oral reactivation and shedding of kshv, we will sequence the V1V3 regions of 16S rrna, which gives high resolution power to differentiate species in the oral microbiome. The findings produced by this study are truly unique and will be fundamental in identifying whether markers of oral disease, oral mucosal inflammation, reduced immune control in the oral cavity, and oral microbiome dysbiosis are factors leading to kshv reactivation in the oral cavity prior to KS development. There is an immense GAP in the research with regards to the effects of oral health and the oral environment on kshv reactivation and KS development. We will incorporate an exceptional multi-disciplinary team of experts with innovative and validated techniques to collect truly unique data on oral health and oral immune response indicators from a rural population in SSA. The inventive direction of this proposal combined with the critical need to identify effects of the oral environment on oral kshv reactivation and shedding, information needed to further the field of research on interventions and therapeutics for KS in plwh, makes my proposal the perfect fit for this catalyst award. The information acquired will substantially expand our knowledge of factors driving kshv reactivation in the oral cavity before KS pathogenesis which is integral to identifying targets for interventions against KS development in SSA in addition to other high-risk populations outside of SSA.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $567,000 | |
| Amendment | $1 | |
| Amendment | -$1 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | -$545,999 | |
| Amendment | $545,999 | |
| Amendment | -$545,999 | |
| Amendment | $545,999 | |
| Amendment | $545,999 | |
| Amendment | -$545,999 | |
| Amendment | $545,999 | |
| Amendment | -$545,999 | |
| Amendment | $546,000 | |
| Amendment | $546,000 | |
| Original award | $546,000 |
Show all 16
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| The Regents Of The University Of Colorado | $21,818 | |
| ADA Forsyth Institute, Inc. | $13,743 |
Quick answers
Who received award DP1CA291173?
DP1CA291173 was awarded to Cincinnati Univ Of by National Cancer Institute (National Institutes of Health) on June 1, 2024.
How much is award DP1CA291173 worth?
$2,205,000 has been obligated on DP1CA291173.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award